{"transactions":[{"id":3031234,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-16T00:13:15.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":2145.264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 2,145.264 shares of the Issuer's Series X1 Convertible Preferred Stock, one quarter of which will become fully vested and exercisable on September 11, 2021, with the remaining 1,608.948 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date. The Reporting Person's ability to exercise the option will be subject to stockholder approval under Nasdaq Marketplace Rule 5635(c)."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Series X1 Convertible Preferred Stock will be convertible into 1,000 shares of Common Stock upon receipt of the requisite approval of the stockholders of the Issuer."}],"balance_after":2145.264,"derivative":{"exercise_price":500,"expiration_date":"2030-09-11","underlying":"Series X1 Convertible Preferred Stock","underlying_shares":2145.264},"source":{"system":"sec-edgar","filing":"0000899243-20-025170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924320025170/doc4.xml","form_type":"4"}},{"id":3199213,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-20T20:30:49.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 19, 2021, with the remaining 37,500 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.26,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-20-009124","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924320009124/doc4.xml","form_type":"4"}},{"id":3404380,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-01T01:30:33.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 60,000 shares of the Issuer's Common Stock, which will vest in equal installments on the first and second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-09-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-19-024433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319024433/doc4.xml","form_type":"4"}},{"id":3515041,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-22T20:02:02.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":1058,"price":1.9114,"value":2022.2612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.90 to $1.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5974,"source":{"system":"sec-edgar","filing":"0001562180-19-003052","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000156218019003052/primarydocument.xml","form_type":"4"}},{"id":3515040,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-22T20:02:02.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":4218,"price":1.9616,"value":8274.0288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.90 to $2.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":7032,"source":{"system":"sec-edgar","filing":"0001562180-19-003052","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000156218019003052/primarydocument.xml","form_type":"4"}},{"id":3590347,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-18T20:23:47.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, which will vest in equal quarterly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":3.72,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-008139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319008139/doc4.xml","form_type":"4"}},{"id":3994497,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-15T22:53:54.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 12,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 13, 2019, with the remaining 9,000 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":12000,"derivative":{"exercise_price":4.83,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-18-007648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318007648/doc4.xml","form_type":"4"}},{"id":3994496,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-15T22:53:54.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date."}],"balance_after":11250,"source":{"system":"sec-edgar","filing":"0000899243-18-007648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318007648/doc4.xml","form_type":"4"}},{"id":4014772,"issuer":{"id":156030,"kind":"organization","name":"EMMAUS LIFE SCIENCES, INC.","symbol":"NONE"},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-03-05T15:46:44.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal (or as close to equal as possible) annual installments, with the first installment to vest on Feb 27, 2019."}],"balance_after":10000,"derivative":{"exercise_price":11.4,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-016344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420031/000120919118016344/doc4.xml","form_type":"4"}},{"id":4259861,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":86903,"kind":"person","name":"Kuwahara Jon","position":1,"cik":"0001664784","reported_name":"Kuwahara Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-10T21:31:05.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 35,000 shares of the Issuer's Common Stock one quarter of which will become fully vested and exercisable on 7/10/2018, with the remaining 26,250 shares vesting in equal quarterly installments over the following three years."}],"balance_after":35000,"derivative":{"exercise_price":5.61,"expiration_date":"2027-07-10","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-17-018152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924317018152/doc4.xml","form_type":"4"}}]}